Advertisement

Research Article Free access | 10.1172/JCI116927

Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).

M F Linton, R V Farese Jr, G Chiesa, D S Grass, P Chin, R E Hammer, H H Hobbs, and S G Young

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100.

Find articles by Linton, M. in: PubMed | Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100.

Find articles by Farese, R. in: PubMed | Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100.

Find articles by Chiesa, G. in: PubMed | Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100.

Find articles by Grass, D. in: PubMed | Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100.

Find articles by Chin, P. in: PubMed | Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100.

Find articles by Hammer, R. in: PubMed | Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100.

Find articles by Hobbs, H. in: PubMed | Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100.

Find articles by Young, S. in: PubMed | Google Scholar

Published December 1, 1993 - More info

Published in Volume 92, Issue 6 on December 1, 1993
J Clin Invest. 1993;92(6):3029–3037. https://doi.org/10.1172/JCI116927.
© 1993 The American Society for Clinical Investigation
Published December 1, 1993 - Version history
View PDF
Abstract

The B apolipoproteins, apo-B48 and apo-B100, are key structural proteins in those classes of lipoproteins considered to be atherogenic [e.g., chylomicron remnants, beta-VLDL, LDL, oxidized LDL, and Lp(a)]. Here we describe the development of transgenic mice expressing high levels of human apo-B48 and apo-B100. A 79.5-kb human genomic DNA fragment containing the entire human apo-B gene was isolated from a P1 bacteriophage library and microinjected into fertilized mouse eggs. 16 transgenic founders expressing human apo-B were generated, and the animals with the highest expression had plasma apo-B100 levels nearly as high as those of normolipidemic humans (approximately 50 mg/dl). The human apo-B100 in transgenic mouse plasma was present largely in lipoproteins of the LDL class as shown by agarose gel electrophoresis, chromatography on a Superose 6 column, and density gradient ultracentrifugation. When the human apo-B transgenic founders were crossed with transgenic mice expressing human apo(a), the offspring that expressed both transgenes had high plasma levels of human Lp(a). Both the human apo-B and Lp(a) transgenic mice will be valuable resources for studying apo-B metabolism and the role of apo-B and Lp(a) in atherosclerosis.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (December 1, 1993): No description
Advertisement
Advertisement